Ranolazine
33 NDCs across 17 manufacturers|33 Generic,0 Brand
Ranolazine is used to treat angina pectoris, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 27, 2006, and the first generic was approved Jul 29, 2013. FDA's Orange Book lists 38 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $111 million on Ranolazine across 1.2 million claims for 301,000 beneficiaries.
Ranolazine is available as 33 NDCs from 17 manufacturers (33 generic, 0 brand), with NADAC prices from $0.16 to $0.28 per EA — a 76% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
33
33G / 0B
Manufacturers
17
competing in market
Price Spread
$0.16 – $0.28
per EA
7d Activity
avg +0.6% WoW · of 33 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Ajanta Pharma USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anti-anginal class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
17 manufacturers producing RANOLAZINE(6 pricing outliers)
Frequently Asked Questions
What is Ranolazine used to treat?
Ranolazine is used to treat angina pectoris, per the National Library of Medicine's MED-RT classification.
When did Ranolazine become available as a generic?
FDA approved the first generic Ranolazine (ANDA) on Jul 29, 2013. The Orange Book currently lists 38 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ranolazine?
In 2024, Medicare Part D spent $111 million on Ranolazine across 1.2 million claims for 301,000 beneficiaries.
How many Ranolazine products are on the market?
The Ranolazine drug market contains 33 NDCs from 17 manufacturers — 33 generic and 0 brand products.
What is the price range for Ranolazine?
NADAC reference prices for Ranolazine range from $0.1609 to $0.2824 per EA — a 76% difference between cheapest and most expensive.
Which manufacturers make Ranolazine?
17 manufacturers list Ranolazine in NADAC. Ranked by number of NDCs, the largest are Ajanta Pharma USA Inc. (4), Unichem Pharmaceuticals (USA) Inc. (2), Sun Pharmaceutical Industries Inc. (2), Glenmark Pharmaceuticals Inc., USA (2), Camber Pharmaceuticals Inc. (2).
How has the price of Ranolazine changed recently?
Over the past 7 days, 15 Ranolazine NDCs rose and 13 fell, with a market-wide average change of +0.6%.